1. Home
  2. VVOS vs CODX Comparison

VVOS vs CODX Comparison

Compare VVOS & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.99

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Logo Co-Diagnostics Inc.

CODX

Co-Diagnostics Inc.

HOLD

Current Price

$0.31

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
CODX
Founded
2016
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
15.6M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
VVOS
CODX
Price
$1.99
$0.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$6.25
$2.25
AVG Volume (30 Days)
123.1K
1.6M
Earning Date
11-19-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,317,000.00
$507,892.00
Revenue This Year
$17.96
N/A
Revenue Next Year
$55.64
$18.89
P/E Ratio
N/A
N/A
Revenue Growth
18.76
N/A
52 Week Low
$1.98
$0.23
52 Week High
$7.95
$1.55

Technical Indicators

Market Signals
Indicator
VVOS
CODX
Relative Strength Index (RSI) 36.71 42.32
Support Level $1.98 $0.34
Resistance Level $2.28 $0.41
Average True Range (ATR) 0.13 0.03
MACD 0.02 -0.00
Stochastic Oscillator 15.31 1.92

Price Performance

Historical Comparison
VVOS
CODX

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: